Sun
Pharma's proposed acquisition of RanbaxyBSE -4.62 % Labs would create a
new market leader in the immensely fragmented Rs 75,000 crore domestic
drug market with the merged entity commanding close 9.3% of market
share.
Sun Pharma, the largest Indian drugmaker by market capitalization said on Monday that it will buy Ranbaxy Labs in a $3.2 billion all-share deal, creating the world's fifth-largest generic drug maker. This is historically the largest domestic deal by size in the Indian pharma space.
Stock Tips for Today:
•BUY WOCKHARDT(LCP-607.15) ABOVE 609 TG-614-619
•BUY TATA COFFEE (LCP 1003.3) ABOVE 1005 TG-1012-1021
•BUY WOCKHARDT(LCP-607.15) ABOVE 609 TG-614-619
•BUY TATA COFFEE (LCP 1003.3) ABOVE 1005 TG-1012-1021
•BUY WOCKHARDT(LCP-607.15) ABOVE 609 TG-614-619
•BUY TATA COFFEE (LCP 1003.3) ABOVE 1005 TG-1012-1021
•BUY WOCKHARDT(LCP-607.15) ABOVE 609 TG-614-619
•BUY TATA COFFEE (LCP 1003.3) ABOVE 1005 TG-1012-1021
Get latest update,news and free stock market tips from our team of analysts does the rigorous work throughout on the basis of the risk-return trade off and comes up with the best trading tips for the customer visit www.capitalheight.com
No comments:
Post a Comment